Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlamydia pneumoniae as a respiratory pathogen.

David L Hahn1, Anthony A Azenabor, Wandy L Beatty

  • 1Arcand Park Clinic, Dean Medical Center, Madison WI 53704, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|February 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LINGO4 coordinates ILC3-intrinsic IL-22 production and microbiota-mediated ILC3 homeostasis.

The Journal of experimental medicine·2026
Same author

Author Correction: Circadian circuits control plasticity of group 3 innate lymphoid cells by sustaining epigenetic configuration of RORγt.

Nature immunology·2026
Same author

Atomic models of the Toxoplasma cell invasion machinery.

Nature structural & molecular biology·2025
Same author

Diagnostic Approach for COPD.

JAMA·2025
Same author

Circadian circuits control plasticity of group 3 innate lymphoid cells by sustaining epigenetic configuration of RORγt.

Nature immunology·2025
Same author

A rapid, simple, and economical method for the isolation of ribosomes and translational machinery for structural and functional studies.

Nature communications·2025

Chlamydia pneumoniae causes respiratory infections, often asymptomatic but sometimes severe. Persistent forms are antibiotic-resistant and linked to chronic lung diseases like asthma and COPD.

Area of Science:

  • Microbiology
  • Immunology
  • Respiratory Medicine

Background:

  • Chlamydia pneumoniae is a significant human respiratory pathogen.
  • It exhibits a unique biphasic life cycle with intracellular replicative and extracellular infectious forms.
  • The organism infects a majority of the global population via the respiratory route.

Purpose of the Study:

  • To investigate the role of Chlamydia pneumoniae in acute and chronic respiratory illnesses.
  • To understand the characteristics of persistent C. pneumoniae infections and their link to chronic lung diseases.
  • To highlight the need for improved diagnostics and treatments for C. pneumoniae.

Main Methods:

  • The study reviews the life cycle and clinical manifestations of C. pneumoniae infections.

Related Experiment Videos

  • It discusses the biological behavior of persistent intracellular inclusions, including heat shock protein 60 (hsp 60) expression.
  • Evidence linking C. pneumoniae infection to chronic inflammatory lung diseases is examined.

    • Main Results:

    • Most acute C. pneumoniae infections are asymptomatic (70%) or mild, but a minority (30%) lead to severe respiratory illnesses like pneumonia and bronchitis.
    • Persistent C. pneumoniae inclusions are metabolically inert, antibiotic-resistant, and associated with prolonged symptoms.
    • Increased chlamydial hsp 60 in persistent infections is implicated in chronic inflammatory disease pathogenesis.

    Conclusions:

    • Chlamydia pneumoniae infection is linked to a spectrum of chronic inflammatory lung diseases, including asthma, chronic bronchitis, and COPD.
    • Effective treatment of acute C. pneumoniae infection and understanding its role in chronic lung conditions require further research.
    • Development of reliable diagnostics and antibiotics effective against persistent C. pneumoniae is crucial.